Albumin is a protein primarily produced by the liver, and it is crucial for maintaining normal physiological functions in the body. It regulates water balance in the blood, transports various molecules (such as drugs, hormones, fatty acids), and helps maintain blood osmotic pressure. The use or supplementation of albumin is typically suited for the following groups of individuals:
CoQ10, or coenzyme Q10, is a naturally occurring, fat-soluble compound found in human cells. Known for its antioxidant properties and its critical role in cellular energy production, CoQ10 has garnered significant attention for its potential benefits in cancer care.
Intralipid is an intravenous nutritional supplement composed primarily of soybean oil, egg yolk lecithin, glycerol, and water. It was originally developed for patients who require intravenous nutrition and is intended to provide essential fatty acids to patients who are unable to obtain nutrition orally. and heat. In recent years, the application of Intralipid in oncology has gradually attracted attention, especially showing potential in helping cancer patients cope with severe weight loss and muscle wasting (i.e. cancer cachexia). For these patients, Intralipid not only stabilizes weight and maintains energy levels, but also supports the body in resisting the side effects of treatment. This article will explore the role of Intralipid in cancer nutrition support and weight management, its potential benefits, and related research.
Heavy metal exposure is a root cause of many health problems, and its potential effects may accumulate over time, leading to chronic conditions such as neurological damage, cardiovascular diseases, and even certain cancers. For some specific groups of people, the risk of heavy metal exposure is higher, and these groups need to pay special attention to their health status and take necessary measures to reduce potential risks.
Cancer is a multifaceted disease influenced by genetic, environmental, and lifestyle factors. Certain groups of individuals are at significantly higher risk of developing cancer due to these factors. For high-risk populations, timely cancer screening plays a crucial role in enabling early detection and intervention, ultimately improving health outcomes.
Immunotherapy has become a breakthrough approach in cancer care, offering new hope for patients by utilizing the body’s immune system to fight cancer. Unlike traditional chemotherapy or radiotherapy, immunotherapy focuses on enhancing the immune system’s ability to recognize and destroy cancer cells. This article will explore the basic principles of immunotherapy, various treatment methods, and its application in cancer management, as well as how testing can help assess the status of the immune system for more accurate treatment decisions.
As the exploration of cancer care methods continues, more patients and healthcare providers are seeking options beyond traditional treatments. Alternative therapies, such as natural therapies and Gerson therapy, have attracted significant attention because they can, in some cases, serve as complementary approaches that enhance the effectiveness of cancer care, reduce side effects, and improve patients’ quality of life. This article will explore the basic concepts, mechanisms, and potential roles of natural therapies and Gerson therapy in cancer care.
VascuStatin is a natural peptide derived from the prolactin precursor protein, gaining attention in the field of oncology due to its potential anti-angiogenic properties. Anti-angiogenesis refers to the process of inhibiting the formation of new blood vessels in tumors, thereby weakening the tumor’s nutrient supply and growth potential. This article explores the potential applications of VascuStatin in cancer care, as well as key findings from experimental and clinical research.
Cancer is a multifactorial disease influenced by genetic, environmental, and lifestyle factors. With advancements in molecular biology and genetic technologies, personalized medicine is becoming a cornerstone of early cancer detection and management. Onco-D-clare, an advanced cancer risk assessment tool, integrates genetic data analysis and molecular diagnostics to provide a comprehensive understanding of individual cancer risks. This article explores the principles, applications, and potential impact of Onco-D-clare on cancer risk management.
PM2.5 (particulate matter less than 2.5 micrometers in diameter) refers to tiny airborne particles that can penetrate deep into the lungs and even enter the bloodstream. These minuscule particles, primarily originating from vehicle emissions, industrial activities, and household combustion, are a major health concern. Long-term exposure to PM2.5 has been linked to various health issues, including respiratory diseases, cardiovascular diseases, and cancer. In recent years, growing evidence suggests a significant association between PM2.5 exposure and the development of certain types of cancer, particularly lung cancer, bladder cancer, and colorectal cancer.